Rang	Name	Position
1	Mr. Chad M. Robins M.B.A.	Co-Founder, CEO & Chairman
2	Ms. Julie Rubinstein	President & COO
3	Mr. Kyle Piskel	VP, CFO & Principal Accounting Officer
4	Ms. Susan Bobulsky	Chief Commercial Officer of MRD
5	Mr. Christopher Carlson Ph.D.	Founder
6	Ms. Karina Calzadilla	VP of Investor Relations and FP&A
7	Ms. Clarice McCauley	Head of Legal, Corporate Secretary, VP & Chief Compliance Officer
8	Mr. Francis T. Lo	Chief People Officer
9	Dr. Sharon Benzeno Ph.D.	Chief Commercial Officer of Immune Medicine
10	Ms. Mary Pat Lancelotta	Senior Vice President, Global Market & Business Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Viking Global Investors LP	18,79%	0,85 Mrd. USD
2	BlackRock Inc	9,49%	0,43 Mrd. USD
3	Vanguard Capital Management, LLC	4,01%	0,18 Mrd. USD
4	Wellington Management Company LLP	3,70%	0,17 Mrd. USD
5	Vanguard Portfolio Management, LLC	3,43%	0,16 Mrd. USD
6	D. E. Shaw & Co LP	2,90%	0,13 Mrd. USD
7	Westfield Capital Management Company, L.P.	2,67%	0,12 Mrd. USD
8	Geode Capital Management, LLC	2,28%	0,10 Mrd. USD
9	State Street Corp	2,17%	0,10 Mrd. USD
10	Amvescap Plc.	1,94%	0,09 Mrd. USD
11	The Goldman Sachs Group Inc	1,87%	0,09 Mrd. USD
12	T. Rowe Price Associates, Inc.	1,67%	0,08 Mrd. USD
13	Driehaus Capital Management LLC	1,58%	0,07 Mrd. USD
14	Arrowstreet Capital Limited Partnership	1,58%	0,07 Mrd. USD
15	Lord, Abbett & Co LLC	1,55%	0,07 Mrd. USD
16	Nuveen, LLC	1,48%	0,07 Mrd. USD
17	BNP Paribas Investment Partners SA	1,37%	0,06 Mrd. USD
18	Fred Alger Management, LLC	1,31%	0,06 Mrd. USD
19	ARK Investment Management LLC	1,31%	0,06 Mrd. USD
20	Delaware Management Holdings Inc	1,18%	0,05 Mrd. USD